Other Cancers Efficacy and Safety of Ixazomib and Daratumumab without Dexamethasone (I-DARA) in Elderly Frail RRMM Patients Jul 28, 2023
Lymphoma,Other Cancers Pembrolizumab as First Treatment for CHL in Older or ABVD-Ineligible Patients Jul 27, 2023
Lymphoma,Other Cancers Baseline PET Radiomics Predicts PMBCL Better Than Clinical Risk Scores Jul 27, 2023
Other Cancers Satuximab, Weekly Carfilzomib, and Dexamethasone as Salvage Therapy for RRMM Jul 27, 2023
